Endo Presents Dupuytren Contracture Data at the IFSSH and IFSHT Triennial Congress
Endo, Inc. (OTCQX: NDOI) announced today that data related to the use of XIAFLEX® (collagenase clostridium histolyticum, or ...
AIG Beats Mallinckrodt Trust in Twist on Opioid Insurance Clash
American International Group Inc.'s successful bid to avoid covering litigation against opioid manufacturing giant ...
Endo, Inc.: Endo Presents Dupuytren Contracture Data at the IFSSH and IFSHT Triennial Congress
Endo, Inc. (OTCQX: NDOI) announced today that data related to the use of XIAFLEX® (collagenase clostridium histolyticum, or CCH) for the treatment ...
How 23andMe’s gene-testing dream turned recessive
She has resigned from the former; the latter does not matter since 23andMe’s equity could be wiped out. If persistence pays off, a company that started out as little more than an intriguing idea and a ...
Knight Therapeutics Reports Fourth Quarter and Year-End 2024 Results
Knight Therapeutics Inc. (TSX: GUD) ("Knight" or “the Company”), a pan-American (ex-US) specialty pharmaceutical company, today reported financial results for its fourth quarter and year ended ...
Purdue Pharma files new bankruptcy plan to resolve opioid claims
Purdue Pharma on Wednesday filed a new Chapter 11 reorganization plan with the U.S. Bankruptcy Court for the Southern ...
pharmaphorum3d
Mallinckrodt moves closer to resolving its opioid liability hangover
Mallinckrodt looks like it could join Purdue Pharma in reaching a settlement in its bankruptcy proceedings related to opioid litigation, after years of legal wrangling. The Ireland-headquartered ...
The Pharma Letter3d
Our Mission
The Pharma Letter offers high value news and insights for people with a professional interest in the global pharmaceutical, biotech, generic and biosimilar industries. Headquartered in London, the ...